Live price temporarily unavailable.
InfuSystem Holdings (INFU) is a Health Care company in the Russell 2000. Latest news and coverage below.
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $70.5M | $71.1M | $67.1M | $81.1M | $97.4M | $102.4M | $109.9M | $125.8M | $134.9M | $143.4M |
| Growth (year over year) | −0.1% | +0.8% | −5.5% | +20.8% | +20.1% | +5.1% | +7.4% | +14.4% | +7.2% | +6.4% |
| Gross profit | $44.7M | $43.4M | $39.6M | $46.9M | $58.8M | $58.5M | $60.6M | $63.1M | $70.4M | $80.3M |
| Gross margin | 63.5% | 61.0% | 58.9% | 57.8% | 60.3% | 57.2% | 55.1% | 50.2% | 52.2% | 56.0% |
| Operating income | $974.0K | −$3.81M | $415.0K | $3.52M | $8.83M | $2.82M | $1.65M | $4.09M | $6.89M | $11.9M |
| Operating margin | 1.4% | −5.4% | 0.6% | 4.3% | 9.1% | 2.8% | 1.5% | 3.2% | 5.1% | 8.3% |
| Net income | −$222.0K | −$20.7M | −$1.09M | $1.36M | $17.3M | $1.42M | $18.0K | $872.0K | $2.35M | $6.63M |
| Net margin | −0.3% | −29.1% | −1.6% | 1.7% | 17.8% | 1.4% | 0.0% | 0.7% | 1.7% | 4.6% |
| EPS (diluted) | −$0.01 | −$0.91 | −$0.05 | $0.07 | $0.80 | $0.06 | $0.00 | $0.04 | $0.11 | $0.31 |
| Balance sheet | ||||||||||
| Cash and equivalents | $3.40M | $3.47M | $4.32M | $2.65M | $9.65M | $186.0K | $165.0K | $231.0K | $527.0K | $3.19M |
| Total assets | $96.3M | $68.9M | $64.1M | $79.2M | $97.0M | $97.6M | $99.4M | $102.9M | $103.6M | $100.6M |
| Total liabilities | $45.7M | $37.9M | $43.6M | $56.9M | $56.2M | $49.3M | $51.4M | $50.6M | $46.1M | $43.2M |
| Long-term debt | $26.6M | $25.4M | $28.8M | $30.3M | $29.4M | $32.7M | $33.2M | $29.1M | $23.9M | $19.6M |
| Shareholders' equity | $50.7M | $31.0M | $20.4M | $22.3M | $40.8M | $48.3M | $48.0M | $52.3M | $57.5M | $57.3M |
| Cash flow | ||||||||||
| Operating cash flow | $7.91M | $7.72M | $11.4M | $13.9M | $20.3M | $18.3M | $17.5M | $11.2M | $20.5M | $24.4M |
| Capital expenditure | $168.0K | $104.0K | $281.0K | $2.93M | $1.09M | $980.0K | $982.0K | $1.02M | $1.09M | $560.0K |
| Free cash flow | $7.74M | $7.61M | $11.1M | $10.9M | $19.2M | $17.3M | $16.5M | $10.2M | $19.4M | $23.8M |
| Share buybacks | $75.0K | — | $10.4M | $0 | $0 | $560.0K | $5.46M | $153.0K | $1.18M | $9.87M |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $35.3M | $33.8M | $34.7M | $36.0M | $36.5M | $36.2M | $33.7M | $36.9M |
| Growth (year over year) | +10.7% | +6.5% | +8.5% | +6.8% | +3.3% | +7.0% | −3.0% | +2.6% |
| Gross profit | $19.0M | $18.2M | $19.2M | $19.9M | $20.8M | $20.4M | $19.7M | $21.4M |
| Gross margin | 53.9% | 53.8% | 55.2% | 55.2% | 57.1% | 56.4% | 58.4% | 58.0% |
| Operating income | $3.27M | $2.62M | $618.0K | $3.78M | $3.81M | $3.71M | $1.59M | $4.15M |
| Operating margin | 9.2% | 7.7% | 1.8% | 10.5% | 10.4% | 10.3% | 4.7% | 11.2% |
| Net income | $1.81M | $933.0K | −$267.0K | $2.60M | $2.26M | $2.04M | $1.02M | $3.23M |
| Net margin | 5.1% | 2.8% | −0.8% | 7.2% | 6.2% | 5.6% | 3.0% | 8.7% |
| EPS (diluted) | $0.08 | $0.05 | −$0.01 | $0.12 | $0.11 | $0.09 | $0.05 | $0.15 |
| Balance sheet | ||||||||
| Cash and equivalents | $380.0K | $527.0K | $1.51M | $720.0K | $955.0K | $3.19M | $2.11M | $964.0K |
| Total assets | $105.3M | $103.6M | $104.3M | $100.8M | $98.9M | $100.6M | $98.7M | $97.7M |
| Total liabilities | $49.8M | $46.1M | $49.1M | $46.3M | $43.4M | $43.2M | $39.9M | $38.6M |
| Long-term debt | $28.0M | $23.9M | $28.7M | $26.3M | $20.9M | $19.6M | $19.6M | $20.4M |
| Shareholders' equity | $55.5M | $57.5M | $55.1M | $54.5M | $55.5M | $57.3M | $58.7M | $59.1M |
| Cash flow | ||||||||
| Operating cash flow | $9.84M | $7.93M | $1.78M | $7.01M | $8.49M | $7.13M | $970.0K | $6.78M |
| Capital expenditure | $43.0K | $530.0K | $131.0K | $217.0K | $79.0K | $133.0K | $157.0K | $91.0K |
| Free cash flow | $9.80M | $7.40M | $1.65M | $6.79M | $8.41M | $6.99M | $813.0K | $6.69M |
| Share buybacks | $698.0K | $199.0K | $2.90M | $3.50M | $2.17M | $1.31M | $809.0K | $3.55M |
From InfuSystem Holdings's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
No recent news mentioning InfuSystem Holdings in our feed yet.